Laboratoires Mayoly Spindler S.A.S. Sustainability Profile
Laboratoires Mayoly Spindler S.A.S., headquartered in France, is a prominent player in the pharmaceutical and healthcare industry. Founded in 1970, the company has established itself as a leader in the development and distribution of innovative medicinal products, particularly in the fields of gastroenterology and dermatology. With a strong presence across Europe and expanding operations in international markets, Mayoly Spindler is renowned for its unique formulations and commitment to quality. The company’s core offerings include prescription medications and over-the-counter products that address various health concerns, setting them apart through rigorous research and development. Recognised for its dedication to patient care and safety, Laboratoires Mayoly Spindler continues to achieve significant milestones, solidifying its market position as a trusted name in healthcare solutions.
DitchCarbon Score
How does Laboratoires Mayoly Spindler S.A.S.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Laboratoires Mayoly Spindler S.A.S.'s score of 31 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Laboratoires Mayoly Spindler S.A.S.'s reported carbon emissions
Laboratoires Mayoly Spindler S.A.S., headquartered in France, has set ambitious climate commitments aimed at significantly reducing its carbon emissions. The company has established targets through the Science Based Targets initiative (SBTi) to reduce absolute Scope 1 and Scope 2 greenhouse gas (GHG) emissions by approximately 48.6% by 2030, using 2019 as the baseline year. Additionally, Mayoly Spindler aims to achieve a 55.0% reduction in Scope 3 emissions per million EUR value added, which encompasses emissions from purchased goods and services, fuel and energy-related activities, upstream transportation and distribution, waste generated in operations, business travel, employee commuting, and end-of-life treatment of sold products. These targets are aligned with the necessary reductions to limit global warming to 1.5°C, reflecting the company's commitment to sustainability within the pharmaceuticals, biotechnology, and life sciences sector. As of now, there is no specific emissions data available for the most recent year, but the outlined commitments demonstrate Mayoly Spindler's proactive approach to addressing climate change and reducing its carbon footprint.
How Carbon Intensive is Laboratoires Mayoly Spindler S.A.S.'s Industry?
How Carbon Intensive is Laboratoires Mayoly Spindler S.A.S.'s Location?
Laboratoires Mayoly Spindler S.A.S.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Laboratoires Mayoly Spindler S.A.S. has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
